Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification
European Heart Journal - Cardiovascular Imaging · 2023
DOI: 10.1093/ehjci/jead070 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2023. Verfasst von Conor J Kane und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Heart Failure, Hypertension, Pulmonary. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Aims
Tricuspid valve regurgitation (TR) is a common valvular disease associated with increased mortality. There is a need for tools to assess the interaction between the pulmonary artery (PA) circulation and the right ventricle in patients with TR and to investigate their association with outcomes. The pulmonary artery pulsatility index (PAPi) has emerged as a haemodynamic risk predictor in left heart disease and pulmonary hypertension (PH). Whether PAPi discriminates risk in unselected patients with greater than or equal to moderate TR is unknown. Methods and results In 5079 patients with greater than or equal to moderate TR (regardless of aetiology) and PA systolic and diastolic pressures measured on their first echocardiogram, we compared all-cause mortality at 5 years based on the presence or absence of PH and PAPi levels. A total of 2741 (54%) patients had PH. The median PAPi was 3.0 (IQR 1.9, 4.4). Both the presence of PH and decreasing levels of PAPi were associated with larger right ventricles, worse right ventricular systolic function, higher NT-pro BNP levels, greater degrees of right heart failure, and worse survival. In a subset of patients who had an echo and right heart catheterization within 24 h, the correlation of non-invasive to invasive PA pressures and PAPi levels was very good (r = 0.76).
Conclusion
In patients with greater than or equal to moderate TR with and without PH, lower PAPi is associated with right ventricular dysfunction, right heart failure, and worse survival. Incorporating PA pressure and PAPi may help stratify disease severity in patients with greater than or equal to moderate TR regardless of aetiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University College Dublin, Dublin, Ireland.
- Department of Cardiovascular Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
- Department of Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
- Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
ORCID-Profile: Ratnasari Padang, Cristina Pislaru, Sorin V Pislaru
Zitieren
APA
Kane, C. J., Lara-Breitinger, K. M., Alabdaljabar, M. S., Nkomo, V. T., Padang, R., Pislaru, C., Kane, G. C., Scott, C., Pislaru, S. V., & Lin, G. (2023). Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead070
Vancouver
Kane CJ, Lara-Breitinger KM, Alabdaljabar MS, Nkomo VT, Padang R, Pislaru C, et al. Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification. European Heart Journal - Cardiovascular Imaging. 2023. doi:10.1093/ehjci/jead070
BibTeX
@article{Kane2023,
author = {Kane, Conor J and Lara-Breitinger, Kyla M and Alabdaljabar, Mohamad S and Nkomo, Vuyisile T and Padang, Ratnasari and Pislaru, Cristina and Kane, Garvan C and Scott, Christopher and Pislaru, Sorin V and Lin, Grace},
title = {Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification},
journal = {European Heart Journal - Cardiovascular Imaging},
year = {2023},
doi = {10.1093/ehjci/jead070}
}
EUVIMED